Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis

PURPOSE: We performed this systematic review and meta-analysis to assess the incidence of fatal adverse events that were associated with the use of programmed cell death ligand 1 (PD-L1) inhibitors, to describe them and to statistically depict factors that were associated with these events. METHOD:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuewen, Wu, Shijie, Chen, Yaying, Shao, Erqian, Zhuang, Tingting, Lu, Linbin, Chen, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006642/
https://www.ncbi.nlm.nih.gov/pubmed/32076409
http://dx.doi.org/10.3389/fphar.2020.00005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006642/
https://www.ncbi.nlm.nih.gov/pubmed/32076409
http://dx.doi.org/10.3389/fphar.2020.00005

Ejemplares similares